8-38234399-G-T
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_015214.3(DDHD2):c.226G>T(p.Gly76Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000837 in 1,572,976 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 9/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_015214.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DDHD2 | NM_015214.3 | c.226G>T | p.Gly76Cys | missense_variant | 3/18 | ENST00000397166.7 | NP_056029.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DDHD2 | ENST00000397166.7 | c.226G>T | p.Gly76Cys | missense_variant | 3/18 | 2 | NM_015214.3 | ENSP00000380352 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00336 AC: 511AN: 152060Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.00121 AC: 261AN: 216346Hom.: 2 AF XY: 0.000958 AC XY: 113AN XY: 117930
GnomAD4 exome AF: 0.000566 AC: 804AN: 1420798Hom.: 2 Cov.: 30 AF XY: 0.000513 AC XY: 362AN XY: 705860
GnomAD4 genome AF: 0.00337 AC: 513AN: 152178Hom.: 2 Cov.: 32 AF XY: 0.00328 AC XY: 244AN XY: 74418
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | DDHD2: BP4, BS2 - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.226G>T (p.G76C) alteration is located in exon 3 (coding exon 2) of the DDHD2 gene. This alteration results from a G to T substitution at nucleotide position 226, causing the glycine (G) at amino acid position 76 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Hereditary spastic paraplegia 54 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Hereditary spastic paraplegia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Oct 05, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at